BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Testicular cancer AND YWHAE, P62258, 7531, ENSG00000108953, 14-3-3 epsilon, FLJ45465, MDS, MDCR, KCIP-1, 14-3-3E
10 results:

  • 1. Therapy-related myelodysplasia and acute myeloid leukemia.
    Bhatia S
    Semin Oncol; 2013 Dec; 40(6):666-75. PubMed ID: 24331189
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [A case of therapy-related leukemia/myelodysplastic syndrome following treatment of refractory testicular germ cell tumor].
    Takizawa A; Miura T; Fujinami K; Osada Y; Tanaka M; Maruta I
    Nihon Hinyokika Gakkai Zasshi; 2005 Nov; 96(7):701-4. PubMed ID: 16363657
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Granulocytic sarcoma of the ovotestis: an association of myelodysplastic syndrome and hermaphroditism.
    Bolaman Z; Kadikoylu G; Kafkas S; Kacar F
    Leuk Lymphoma; 2004 Jun; 45(6):1285-7. PubMed ID: 15360014
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Therapy-related acute lymphoblastic leukaemia with MLL rearrangements following DNA topoisomerase II inhibitors, an increasing problem: report on two new cases and review of the literature since 1992.
    Andersen MK; Christiansen DH; Jensen BA; Ernst P; Hauge G; Pedersen-Bjergaard J
    Br J Haematol; 2001 Sep; 114(3):539-43. PubMed ID: 11552977
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The incidence of secondary leukemias.
    Leone G; Mele L; Pulsoni A; Equitani F; Pagano L
    Haematologica; 1999 Oct; 84(10):937-45. PubMed ID: 10509043
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumors.
    Kollmannsberger C; Beyer J; Droz JP; Harstrick A; Hartmann JT; Biron P; Fléchon A; Schöffski P; Kuczyk M; Schmoll HJ; Kanz L; Bokemeyer C
    J Clin Oncol; 1998 Oct; 16(10):3386-91. PubMed ID: 9779717
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Marrow and stem cell transplantation in Oklahoma: fifteen years of experience and results.
    Mandanas RA; Carter TH; Epstein RB; Roy V; Selby GB
    J Okla State Med Assoc; 1998 Sep; 91(6):339-46. PubMed ID: 9763768
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Risk of secondary myeloid leukemia and myelodysplastic syndrome following standard-dose chemotherapy or high-dose chemotherapy with stem cell support in patients with potentially curable malignancies.
    Kollmannsberger C; Hartmann JT; Kanz L; Bokemeyer C
    J Cancer Res Clin Oncol; 1998; 124(3-4):207-14. PubMed ID: 9619748
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Risk of acute myelogenous leukaemia and myelodysplasia following cancer treatment.
    van Leeuwen FE
    Baillieres Clin Haematol; 1996 Mar; 9(1):57-85. PubMed ID: 8730551
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Involvement of 11p15 and 3q21q26 in therapy-related myeloid leukemia (t-ML) in children. Case reports and review of the literature.
    Stark B; Jeison M; Shohat M; Goshen Y; Vogel R; Cohen IJ; Yaniv I; Kaplinsky C; Zaizov R
    Cancer Genet Cytogenet; 1994 Jul; 75(1):11-22. PubMed ID: 8039158
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.